immunotherapies
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
immunotherapies
May 5, 2024, 13:13 |
Blog
Dr. Tim Greten receives 2024 Innovation Grant from the Cholangiocarcinoma Foundation! - NCI Center for Cancer Research
NCI Center for Cancer Research shared on LinkedIn: "STAFF SPOTLIGHT: Congratulations to Dr. Tim Greten, the…
Apr 26, 2024, 07:04 |
Blog
Rudi Schmidt: The PD1/PD-L1 checkpoint pathway is almost exclusively associated with cancer and immunotherapies
Rudi Schmidt, Chief Operating Officer at Institute for Healthier Living Abu Dhabi, shared on LinkedIn:…
Mar 25, 2024, 12:39 |
Insight
Patrick Hwu: This study demonstrates the importance of vaccine route when designing cancer immunotherapies
Patrick Hwu, President and CEO at Moffitt Cancer Center, posted on X/Twitter: "For cancer vaccines…
Mar 20, 2024, 16:11 |
Blog
On March 21st let's talk about Anal Cancer
Anal Cancer Awareness Day Anal cancer is one of the less discussed cancer types. It…
Jan 24, 2024, 08:34 |
Blog
Angelo Dipasquale: Which patient may benefit from inclusion in an early-phase trial with next-generation immunotherapies?
Angelo Dipasquale, Medical Oncologist at the Humanitas Research Hospital, shared a post on LinkedIn: "Which…
Dec 10, 2023, 17:26 |
Career
Mark Awad was honored by GO2 for Lung Cancer at the 18th Annual Simply the Best Gala - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute posted on LinkedIn: "Congratulations to Mark Awad, MD, PhD who was honored…
Jul 11, 2023, 15:33 |
Drugs
First patient dosed in combination trial of OBT076 and CPI Balstilimab - Oxford BioTherapeutics
We are pleased to announce that the first patient has been dosed in a Phase…
All:
7
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube